Taking any neuroprotective is a tricky thing.Nobody knows what their rate of progession is.So how can we tell if our rate has been slowed.The solution to the problem would be a larfge phase111 trial.Why the government tells us they are interested in developing a neuroprotective and has not started a trial is beyond my imagination.